- Trials with a EudraCT protocol (731)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
731 result(s) found for: neuropathy.
Displaying page 19 of 37.
EudraCT Number: 2016-004383-19 | Sponsor Protocol Number: GORTEC_2017-01 | Start Date*: 2017-09-07 | |||||||||||
Sponsor Name:GORTEC | |||||||||||||
Full Title: A Phase III randomized trial of avelumab-cetuximab-Radiotherapy versus standards of care in locally advanced squamous cell carcinoma of the head and neck | |||||||||||||
Medical condition: Squamous cell carcinoma, previously untreated Stage III, stage IVa (i.e. operable, but not operated) or IVb (non resectable) Oral cavity, oropharynx, hypopharynx or larynx | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000079-18 | Sponsor Protocol Number: PHN-BBFC-NI101 | Start Date*: 2020-03-18 | |||||||||||||||||||||
Sponsor Name:Pharmathen S.A. | |||||||||||||||||||||||
Full Title: A phase III, multicentre, prospective, randomized, assessor-blinded, two-arm, parallel group, therapeutic non-inferiority 3-month clinical trial to compare the efficacy and safety of a generic fixe... | |||||||||||||||||||||||
Medical condition: Open-angle glaucoma (OAG) or ocular hypertension (OHT) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GR (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004998-53 | Sponsor Protocol Number: OMB116024 | Start Date*: 2013-02-05 |
Sponsor Name:National and Kapodistrian University of Athens | ||
Full Title: A phase II study of the efficacy of the combination of ofatumumab with fludarabine and cyclophosphamide in patients with relapsed or refractory Waldenström’s Macroglobulinemia. | ||
Medical condition: Relapsed or refractory Waldenström’s Macroglobulinemia. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-003657-24 | Sponsor Protocol Number: BRIL06 | Start Date*: 2006-09-06 | |||||||||||
Sponsor Name:GIMURELL | |||||||||||||
Full Title: A PHASE II MULTICENTER NON-RANDOMIZED STUDY TO ASSESS SAFETY, TOXICITY AND CLINICAL ACTIVITY OF THE ASSOCIATION OF BORTEZOMID VELCADE WITH RITUXIMAB IN RELAPSED/REFRACTORY INDOLENT NON FOLLICULAR... | |||||||||||||
Medical condition: relapsed non follicular non-Hodgkin s Lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001270-24 | Sponsor Protocol Number: A3671014 | Start Date*: 2007-02-13 | |||||||||||
Sponsor Name:Pfizer Pharma GmbH | |||||||||||||
Full Title: Phase 2, single arm study of ticilimumab in patients with refractory metastatic adenocarcinoma of the colon or rectum | |||||||||||||
Medical condition: Refractory meatstatic adenocarcinoma of the colon or rectum | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004562-40 | Sponsor Protocol Number: GOG-0146Q | Start Date*: 2008-01-14 | |||||||||||
Sponsor Name:Gynecologic Oncology Group | |||||||||||||
Full Title: A PHASE II EVALUATION OF TOPOTECAN ADMINISTERED WEEKLY IN THE TREATMENT OF RECURRENT PLATINUM-SENSITIVE OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER | |||||||||||||
Medical condition: Patients with recurrent ovarian, fallopian tube, or primary peritoneal cancers. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021016-41 | Sponsor Protocol Number: 10.05 | Start Date*: 2011-01-14 | |||||||||||
Sponsor Name:Odense University Hospital | |||||||||||||
Full Title: Dose determination of Taxotere®, Eloxatin® and Xeloda® (TEX) in combination with Herpectin® as first line treatment to patients with HER2-positive non-resectable esophagus, cardia or gastric cancer | |||||||||||||
Medical condition: Esophagus, cardiac or ventricular cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001074-15 | Sponsor Protocol Number: GEN701 | Start Date*: 2013-10-08 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Genmab A/S | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: First-in-human, dose-escalating safety study of tissue factor specific antibody drug conjugate tisotumab vedotin (HuMax®-TF-ADC) in patients with locally advanced and/or metastatic solid tumors kno... | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Cancer of the ovary, cervix, endometrium, bladder, prostate (castration-resistant prostate cancer [CRPC]), head and neck (squamous cell carcinoma of the head and neck [SCCHN]), esophagus or lung (n... | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-002797-56 | Sponsor Protocol Number: C04-2 | Start Date*: 2007-08-28 | |||||||||||
Sponsor Name:Gercor | |||||||||||||
Full Title: Phase III study of an optimized chemotherapy + Avastin strategy +/- Tarceva in metastatic colorectal cancer. | |||||||||||||
Medical condition: Metastatic Colorectal Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002131-32 | Sponsor Protocol Number: SP001033 | Start Date*: 2008-04-17 | |||||||||||
Sponsor Name:ASSOCIAZIONE ITALIANA PER LO STUDIO DEL DOLORE | |||||||||||||
Full Title: A RANDOMIZED, OPEN COMPARISON BETWEEN PREGABALIN/TRANSDERMAL BUPRENORPHINE AND PREGABALIN/DICLOFENAC IN CHRONIC NEUROPATHIC PAIN PATIENTS | |||||||||||||
Medical condition: PERIPHERAL NEUROPATHIC PAIN DUE TO POST-HERPETIC NEURALGIA OR DIABETIC POLYNEUROPATHY | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002231-18 | Sponsor Protocol Number: RMHCAN1104 | Start Date*: 2015-12-01 | |||||||||||
Sponsor Name:University Southampton Hospital NHS Foundation Trust | |||||||||||||
Full Title: A Phase I/IIa Study of Targeted Radiotherapy alone for Stem Cell Transplant Conditioning in Systemic AL Amyloidosis | |||||||||||||
Medical condition: AL-Amyloidosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001494-88 | Sponsor Protocol Number: ET19-073 | Start Date*: 2019-08-03 |
Sponsor Name:Centre Léon Bérard | ||
Full Title: MegaMOST - A multicenter, open-label, biology driven, Phase II study evaluating the activity of anti-cancer treatments targeting tumor molecular alterations/characteristics in advanced / metastatic... | ||
Medical condition: all histological types of advanced / metastatic tumors with alterations molecular identified | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004348-47 | Sponsor Protocol Number: SOGUG-2017-A-IEC(VEJ)-4 | Start Date*: 2019-07-10 | |||||||||||
Sponsor Name:Grupo Español de Oncología Genitourinaria (SOGUG) | |||||||||||||
Full Title: EFFICACY OF ATEZOLIZUMAB CONCURRENT WITH RADIOTHERAPY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER | |||||||||||||
Medical condition: MUSCLE-INVASIVE BLADDER CANCER | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004963-68 | Sponsor Protocol Number: 26866138-LUC-2006 | Start Date*: 2007-10-16 | |||||||||||
Sponsor Name:Prof Vassilis Georgoulias | |||||||||||||
Full Title: A Phase II, Open-Label Trial of Bortezomib (Velcade®) in Combination with Gemcitabine and Cisplatin in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer. | |||||||||||||
Medical condition: First Line treatment for Locally Advanced or Metastatic Non-Small Cell Lung Cancer. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005090-22 | Sponsor Protocol Number: 001 | Start Date*: 2012-02-28 | |||||||||||
Sponsor Name:Southend Hospital | |||||||||||||
Full Title: A study of efficacy and safety of delayed release prednisone in newly diagnosed cases of Giant Cell Arteritis | |||||||||||||
Medical condition: Giant Cell Arteritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001288-32 | Sponsor Protocol Number: I3CPh1-FSM-01.11 | Start Date*: 2011-04-18 | |||||||||||
Sponsor Name:FONDAZIONE SALVATORE MAUGERI - CLINICA DEL LAVORO E DELLA RIABILITAZIONE | |||||||||||||
Full Title: A Pilot Study to Evaluate the Safety and Tolerability of the combination ot Trabectidin and Indole-3-Carbinol in refractory ER-positive metastatic breast cancer | |||||||||||||
Medical condition: Refractory ER-positive metastatic breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003201-14 | Sponsor Protocol Number: ERTUSO | Start Date*: 2012-03-02 | |||||||||||
Sponsor Name: Krankenhaus Nordwest GmbH | |||||||||||||
Full Title: Phase I/II, Open Label, Dose Escalating Study To Investigate Safety, Tolerability, And Preliminary Efficacy Of The Trifunctional Anti-HER-2/neu x Anti-CD3 Antibody Ertumaxomab In Patients With HER-... | |||||||||||||
Medical condition: Patients with HER2/neu (1+/SISH positive, 2+ and 3+) expressing solid tumors that are progressing after standard therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014336-38 | Sponsor Protocol Number: 2009-02-SUN-Case | Start Date*: 2009-10-09 | ||||||||||||||||
Sponsor Name:Universitätsmedizin der Johannes Gutenberg-University Mainz | ||||||||||||||||||
Full Title: A randomized, placebo-controlled phase II trial investigating SUNITINIB versus placebo in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus treated with chemot... | ||||||||||||||||||
Medical condition: Chemo-refractory advanced or metastatic adenocarcinoma of stomach or lower esophagus | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-000236-94 | Sponsor Protocol Number: TTD-13-01 | Start Date*: 2013-06-05 | |||||||||||
Sponsor Name:Grupo de Tratamiento de los Tumores Digestivos (TTD) | |||||||||||||
Full Title: Phase II study of Regorafenib as a single agent for first-line treatment of patients with metastatic colorectal cancer (MCRC) who are fragile and/or not candidates for polychemotherapy | |||||||||||||
Medical condition: Metastatic colorectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002267-15 | Sponsor Protocol Number: GluST1_vers4_2014 | Start Date*: 2014-07-31 | |||||||||||
Sponsor Name:Hvidovre Hospital | |||||||||||||
Full Title: Treatment of hypoglycemia with glucagon among patients with type 1 diabetes mellitus | |||||||||||||
Medical condition: Patients with type 1 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.